Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Liberty Live-C
LLYVK
5
American Express
AXP
MY Stock MarketDetailed Quotes
7081 PHARMA
- 0.290
- +0.035+13.73%
15min DelayTrading May 8 09:29 CST
417.96MMarket Cap3.15P/E (TTM)
0.295High0.275Low10.75MVolume0.275Open0.255Pre Close3.07MTurnover0.47052wk High2.20%Turnover Ratio1.44BShares0.20052wk Low0.092EPS TTM141.69MFloat Cap1.267Historical High3.15P/E (Static)488.58MShs Float0.067Historical Low0.092EPS LYR7.84%Amplitude--Dividend TTM-2.44P/B100Lot Size--Div YieldTTM
PHARMA Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.43%3.76B | 17.30%926.44M | 16.30%1.03B | -1.23%838.26M | 9.60%964.96M | -2.20%3.4B | -8.45%789.81M | -1.06%885.49M | 11.51%848.73M | -8.49%880.45M |
| Cost of revenue | 3.95%3.22B | 4.71%820.29M | 3.50%802.35M | 0.39%754.69M | 7.04%841.65M | -16.09%3.1B | -41.64%783.39M | -6.10%775.22M | 11.16%751.76M | -7.10%786.29M |
| Gross profit | 75.59%540.49M | 1,553.96%106.15M | 106.29%227.47M | -13.82%83.57M | 30.95%123.31M | 246.87%307.82M | 101.34%6.42M | 59.01%110.27M | 14.30%96.97M | -18.69%94.17M |
| Operating expense | -14.84%279.57M | 161.57%75.99M | -52.48%71.76M | -15.76%63.98M | -6.11%67.84M | 4.42%328.27M | -70.55%29.05M | 104.03%151.01M | 6.94%75.94M | 2.21%72.26M |
| Other operating expenses | -14.84%279.57M | 161.57%75.99M | -52.48%71.76M | -15.76%63.98M | -6.11%67.84M | --328.27M | --29.05M | 104.03%151.01M | 6.94%75.94M | 2.21%72.26M |
| Operating profit | 1,376.17%260.93M | 233.28%30.17M | 482.14%155.71M | -6.85%19.59M | 153.19%55.47M | 96.10%-20.45M | 96.09%-22.63M | -772.34%-40.75M | 52.14%21.03M | -51.44%21.91M |
| Net non-operating interest income (expenses) | -15.49%-69.72M | -11.13%-17.74M | -9.60%-17.37M | -16.02%-17.67M | -27.13%-16.93M | -54.28%-60.37M | -29.96%-15.96M | -64.90%-15.85M | -62.65%-15.23M | -69.30%-13.32M |
| Non-operating interest income | 52.47%2.25M | 27.10%394K | 148.04%888K | 256.16%520K | -32.13%450K | 62.31%1.48M | 30.25%310K | 184.13%358K | -33.64%146K | 103.37%663K |
| Non-operating interest expense | 16.37%71.97M | 11.43%18.13M | 12.65%18.26M | 18.30%18.19M | 24.32%17.38M | 54.46%61.84M | 29.97%16.27M | 66.44%16.21M | 60.44%15.38M | 70.66%13.98M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 12.16%2.97M | -22.92%891K | -56.51%147K | 158.55%1.42M | -15.54%511K | -1.67%2.65M | -49.87%1.16M | 160.00%338K | 720.90%550K | 216.75%605K |
| Income before tax | 348.43%194.18M | 135.57%13.32M | 346.16%138.49M | -47.43%3.33M | 324.71%39.04M | 87.20%-78.16M | 94.14%-37.44M | -297.51%-56.26M | 40.28%6.34M | -75.45%9.19M |
| Income tax | 10,293.46%60.39M | 509.77%10.87M | 615.34%37.17M | -112.74%-512K | 100.17%12.87M | -96.60%581K | -145.71%-2.65M | -678.83%-7.21M | 11.39%4.02M | -25.12%6.43M |
| Net income | 269.91%133.79M | 107.04%2.45M | 306.58%101.32M | 65.49%3.85M | 846.46%26.18M | 87.45%-78.74M | 94.60%-34.79M | -270.81%-49.05M | 154.27%2.32M | -90.41%2.77M |
| Net income continuous operations | 269.91%133.79M | 107.04%2.45M | 306.58%101.32M | 65.49%3.85M | 846.46%26.18M | 87.45%-78.74M | 94.60%-34.79M | -270.81%-49.05M | 154.27%2.32M | -90.41%2.77M |
| Noncontrolling interests | 39.27%1.97M | -83.96%103K | -1.71%287K | 188.98%1.05M | 351.69%533K | -37.54%1.42M | 232.64%642K | -61.58%292K | 89.06%363K | -89.48%118K |
| Net income attributable to the company | 264.45%131.82M | 106.62%2.35M | 304.77%101.03M | 42.63%2.8M | 868.50%25.65M | 87.27%-80.16M | 94.50%-35.43M | -252.75%-49.34M | 171.61%1.96M | -90.45%2.65M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 264.45%131.82M | 106.62%2.35M | 304.77%101.03M | 42.63%2.8M | 868.50%25.65M | 87.27%-80.16M | 94.50%-35.43M | -252.75%-49.34M | 171.61%1.96M | -90.45%2.65M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 256.14%0.0915 | 106.18%0.0016 | 291.01%0.0701 | 26.67%0.0019 | 790.00%0.0178 | 87.81%-0.0586 | 94.73%-0.0259 | -242.99%-0.0367 | 150.00%0.0015 | -90.57%0.002 |
| Diluted earnings per share | 256.14%0.0915 | 106.18%0.0016 | 291.01%0.0701 | 26.67%0.0019 | 790.00%0.0178 | 87.81%-0.0586 | 94.73%-0.0259 | -242.99%-0.0367 | 150.00%0.0015 | -90.57%0.002 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting